Fresenius Medical Care’s New Voting‑Rights Move Signals Strategic Capital‑Market and Innovation Shift
Fresenius Medical Care’s December 30, 2025 filing reveals a subtle shift in voting rights, a pre‑emptive capital‑market release, and a new CMO—offering clues to its governance, funding strategy and future innovation focus in the competitive dialysis…
6 minutes to read









